Janika Viereck

Feodor Lynen Str. 15
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

MiR-132 inhibition improves myocardial strain in a large animal model of chronic left ventricular adverse remodelling.

MiR-132 inhibition improves myocardial strain in a large animal model of chronic left ventricular adverse remodelling.

Journal: European heart journal. Imaging methods and practice

Published: January 06, 2025

Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial.

Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial.

Journal: European journal of heart failure

Published: September 02, 2023

Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark Genome.

Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark Genome.

Journal: JACC. Basic to translational science

Published: August 02, 2023

AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes.

AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: November 24, 2021

ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.

ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.

Journal: Circulation. Heart failure

Published: July 12, 2021

AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.

AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.

Journal: Journal of the American College of Cardiology

Published: March 05, 2021

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study.

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study.

Journal: European heart journal

Published: September 22, 2020

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure.

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure.

Journal: European heart journal

Published: February 07, 2020

miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury.

miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury.

Journal: International journal of molecular sciences

Published: December 13, 2019

Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19.

Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19.

Journal: Journal of molecular and cellular cardiology

Published: July 22, 2019

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.

Journal: European heart journal

Published: June 04, 2019

Preclinical development of a miR-132 inhibitor for heart failure treatment.

Preclinical development of a miR-132 inhibitor for heart failure treatment.

Journal: Nature communications

Published: April 26, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026